LEADIANT GMBH

Italy

All drugs from this manufacturer

  • CHENODEOXYCHOLIC ACID LEADIANT

    It is used to treat cerebrotendinous xanthomatosis (CTX), a rare condition in which the absence of chenodeoxycholic acid causes the accumulation of fat deposits in the body.

    Dosage form: capsules, hard gelatin

    Active substance Dosage
    chenodeoxycholic acid -

    ATC: A05AA01

  • This medicine is used for the treatment of certain types of tumors, including Hodgkin's lymphoma, lymphosarcoma, reticulosarcoma, and Brill-Symmers disease. In children and adolescents between 2 and 18 years of age, it is indicated for Hodgkin's lymphoma, but only if administered together with other anticancer drugs according to a medical protocol.

    Dosage form: capsules, hard gelatin

    Active substance Dosage
    procarbazine -

    ATC: L01XB01